Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease
| Autor: | Anandita Agarwala, Lauren Hassen, Aneesha Thobani, Laxmi S. Mehta |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Statin medicine.drug_class Hypercholesterolemia Disease Pregnancy Risk Factors Hyperlipidemia medicine Humans Intensive care medicine Angiology Dyslipidemias Atherosclerotic cardiovascular disease business.industry Atherosclerotic disease nutritional and metabolic diseases medicine.disease Atherosclerosis Cardiovascular Diseases Female Pregnant Women Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Dyslipidemia |
| Zdroj: | Current atherosclerosis reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(10) |
| ISSN: | 1534-6242 |
| Popis: | In this review, we discuss strategies for managing dyslipidemia in pregnant women with ASCVD. Cardiovascular disease (CVD) is the leading cause of mortality in women as well as the leading cause of pregnancy-related mortality in the USA. It is paramount to screen, identify, counsel, and treat women of childbearing age who have existing atherosclerotic disease to mitigate the risks of complications and mortality. Dyslipidemias, including hypercholesterolemia and hyperlipidemia, can further enhance the risk for future CVD events. Treating hypercholesterolemia during pregnancy is crucial, and this is an opportune time for cross-collaboration of subspecialties in cardiology, obstetrics, and gynecology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink